Literature DB >> 10066091

Transformation of rat glioma cells with the M-CSF gene inhibits tumorigenesis in vivo.

H Yoshioka1, S Hama, T Sadatomo, E Taniguchi, K Harada, K Sugiyama, F Kimura, K Motoyoshi, K Kurisu.   

Abstract

Macrophage colony-stimulating factor (M-CSF) is a potent stimulator of the effector cells such as monocytes and macrophages. To evaluate the effect of M-CSF on malignant gliomas, we transfected the rat gliosarcoma cell line (9L) with human M-CSF expression vector (pCEF-MCSF) by a liposome method. Transfectants were selected using G418-containing medium. As a control, 9L cells transfected with pRc/CMV and selected by G418 were used. The effects of M-CSF gene transfection on tumor cell proliferation in vitro and in vivo were examined. All growth rate did not change in vitro. While the control 9L cells formed progressively enlarging masses, 9L cells transfected with the M-CSF gene did not develop into tumors after the injection into rats. On the other hand, in rats receiving anti-asialo GM1 antibody, 9L cells transfected with M-CSF gene developed into tumors, though at a slower rate than control 9L cells. Histologic examination after transplantation of 9L cells transfected with M-CSF gene disclosed intense infiltration of macrophages in the tumor. Thus M-CSF gene transfection into glioma cells stimulates an antitumor effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10066091     DOI: 10.1023/a:1006177328576

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  49 in total

1.  Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.

Authors:  A Sampson-Johannes; J A Carlino
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

2.  Tumor vaccination with macrophage colony-stimulating factor-producing Lewis lung carcinoma in mice.

Authors:  T Morita; K Ikeda; M Douzono; M Yamada; F Kimura; K Kawakami; K Sasaki; K Motoyoshi; J Takahara; S Irino
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

3.  Demonstration of a rational strategy for human prostate cancer gene therapy.

Authors:  M G Sanda; S R Ayyagari; E M Jaffee; J I Epstein; S L Clift; L K Cohen; G Dranoff; D M Pardoll; R C Mulligan; J W Simons
Journal:  J Urol       Date:  1994-03       Impact factor: 7.450

4.  Augmentation of antitumor immunity using genetically M-CSF-expressing L1210 cells.

Authors:  F Kimura; M Douzono; J Ohta; T Morita; K Ikeda; Y Nakamura; K Sato; M Yamada; N Nagata; K Motoyoshi
Journal:  Exp Hematol       Date:  1996-02       Impact factor: 3.084

5.  Human monocyte to macrophage differentiation in vitro: characterization and mechanisms of the increased antibody-dependent cytotoxicity associated with differentiation.

Authors:  A L Sagone; J J Rinehart
Journal:  J Leukoc Biol       Date:  1984-02       Impact factor: 4.962

6.  Macrophage colony-stimulating factor (M-CSF) enhances the capacity of murine macrophages to secrete oxygen reduction products.

Authors:  E J Wing; N M Ampel; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

7.  Macrophage colony-stimulating factor enhances monocyte and macrophage antibody-dependent cell-mediated cytotoxicity.

Authors:  R A Mufson; J Aghajanian; G Wong; C Woodhouse; A C Morgan
Journal:  Cell Immunol       Date:  1989-03       Impact factor: 4.868

8.  Effects of IL-12 on helper T cell-dependent immune responses in vivo.

Authors:  A J McKnight; G J Zimmer; I Fogelman; S F Wolf; A K Abbas
Journal:  J Immunol       Date:  1994-03-01       Impact factor: 5.422

9.  Stimulation of macrophage tumoricidal activity by the growth and differentiation factor CSF-1.

Authors:  P Ralph; I Nakoinz
Journal:  Cell Immunol       Date:  1987-04-01       Impact factor: 4.868

10.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

View more
  2 in total

1.  Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus.

Authors:  Aouatef Djeraba; Eugène Musset; John W Lowenthal; David B Boyle; Anne-Marie Chaussé; Michele Péloille; Pascale Quéré
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Antitumor immunity induced by irradiated tumor cells producing macrophage colony-stimulating factor.

Authors:  S Suzu; F Kimura; M Tanaka-Douzono; M Yamada; Y Nakamura; N Wakimoto; K Sato; T Morita; K Ikeda; K Motoyoshi
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.